FDA clears Toshibas VeloCT console upgrade

Evan Godt | | Health Imaging | Diagnostic Imaging
Toshiba America Medical Systems’ VeloCT, a console upgrade for existing systems, has received FDA clearance and is now available.

VeloCT features enhancements for patient safety, dose management and workflow for Aquilion 32, Aquilion 64 and Aquilion CX CT systems manufactured between 2006 and 2012, including:
  • Adaptive Iterative Dose Reduction 3D software that reduces noise, allowing for lower radiation dose.
  • NEMA XR 25 Dose Check software with Dose Alert and Dose Notification tools to increase user awareness of dose being administered to patients.
  • Tracking and DICOM IHE Structured Dose Report for dose management and reporting.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.